Clinical Trials Directory

Trials / Completed

CompletedNCT02078700

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Azienda USL Reggio Emilia - IRCCS · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this phase 2 study is to evaluate the feasibility of an early palliative care intervention for metastatic cancer patients. Feasibility will be assessed in terms of percentage of patients that accept the proposal of the early palliative care intervention and that effectively start to be followed in the palliative care out-patient clinic. The study will be performed in a consecutive series of newly diagnosed patients affected by lung cancer (NSCLC or SCLC, stage IIIb, IV), mesothelioma (stage II, IV), pancreas (stage IV), stomach (stage IIIb-IV).

Conditions

Interventions

TypeNameDescription
OTHERThe early palliative care programmeThe intervention consists of an early integration of a palliative care programme with the standard care performed by the oncologists-pneumologists that are following the cancer patients. The intervention will be delivered by the specialised Palliative Care Unit (PCU) of the hospital. Each patient meets the professionals of the PCU by 30 days by cancer diagnosis and at least monthly thereafter in the outpatint settings.

Timeline

Start date
2013-07-01
Primary completion
2014-04-01
Completion
2014-12-01
First posted
2014-03-05
Last updated
2025-06-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02078700. Inclusion in this directory is not an endorsement.